 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific...

Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Shares of Merus (NASDAQ:MRUS - Get Free Report) have been assigned an average recommendation of "Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports...

Merus (NASDAQ:MRUS) Receives $52.00 Consensus PT from Brokerages

This indicator may be signaling MRUS's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Merus (MRUS, $45.03) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Merus initiated with bullish view at Truist, here's why

Shares of Merus (NASDAQ:MRUS  Get Free Report) fell 4% on Monday . The stock traded as low as $44.00 and last traded at $44.09. 69,244 shares traded hands during mid-day trading, a decline of...

Merus (NASDAQ:MRUS)  Shares Down 4%

Merus (NASDAQ:MRUS  Get Free Report) and CohBar (NASDAQ:CWBR  Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based...

Merus (NASDAQ:MRUS) and CohBar (NASDAQ:CWBR) Critical Analysis

This is a signal that MRUS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Merus (MRUS, $46.84) Stochastic Oscillator left the oversold zone on March 21, 2024

Shares of Merus (NASDAQ:MRUS  Get Free Report) traded down 5.2% during mid-day trading on Tuesday . The stock traded as low as $45.09 and last traded at $45.24. 488,486 shares changed hands...

Merus (NASDAQ:MRUS) Trading Down 5.2%

This indicator may be signaling that MRUS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Merus (MRUS, $45.94) entered Downtrend as Momentum indicator drops below 0 level on Mar 12, 2024

Merus (MRUS, $47.73) entered Uptrend as Momentum indicator ascends above 0 level on Mar 11, 2024

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Volume (M)	243,100.00
52-Wk High	$52.04
52-Wk Low	$18.21

MRUS Merus N.V

About

Feed

News

Sentiment

Earnings

Fundamentals